(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride is a key chiral intermediate in the synthesis of aprepitant, a neurokinin-1 (NK1) receptor antagonist. Aprepitant is an active pharmaceutical ingredient (API) used for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). This compound features a morpholine core substituted with a 4-fluorophenyl group and a chiral side chain containing a 3,5-bis(trifluoromethyl)phenyl moiety. The specific stereochemistry (2R,3S,1'R) is crucial for its biological activity as a precursor to aprepitant. Its synthesis and application are central to the production of this important antiemetic drug. The hydrochloride salt form enhances its stability and handling properties for pharmaceutical manufacturing. The presence of multiple fluorine atoms and the complex chiral structure make it a sophisticated building block in medicinal chemistry, specifically targeted for the development of neurokinin receptor antagonists.